Adding erythropoietin to intravenous methylprednisolone in acute treatment of attacks of neuromyelitis optica spectrum disorders: A randomized controlled trial

Background: Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune disease of the central nervous system (CNS) that prompts immediate potent treatment. Delaying treatment could leave debilitating sequelae. As erythropoietin (EPO) has shown neuroprotective effects, we studied the effects of...

Descripción completa

Detalles Bibliográficos
Autores principales: Shafaei, Maryam, Ghadiri, Fereshteh, Azimi, Amirreza, Moghadasi, Abdorreza Naser, Hakiminezhad, Mahdi, Sahraian, Mohammad Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189199/
https://www.ncbi.nlm.nih.gov/pubmed/38011377
http://dx.doi.org/10.18502/cjn.v21i4.11715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189199/
https://www.ncbi.nlm.nih.gov/pubmed/38011377
http://dx.doi.org/10.18502/cjn.v21i4.11715

Ejemplares similares